JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4326
iShares 0-5 Year TIPS Bond ETF
STIP
$16.4B
| $18K | ﹤0.01% |
+179
| New | +$18.1K |
2017 Q2
0 quarters
|
|
4327
Timberland Bancorp
TSBK
$354M
| $18K | ﹤0.01% |
714
-1,041
| -59% | -$23.7K |
2016 Q4
2 quarters
|
|
|
CDMO
4328
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $18K | ﹤0.01% |
4,286
| – | – |
2015 Q1
9 quarters
|
|
|
ADMS
4329
DELISTED
Adamas Pharmaceuticals
ADMS
| $18K | ﹤0.01% |
1,038
-152,725
| -99% | -$2.53M |
2014 Q2
12 quarters
|
|
|
KEG
4330
DELISTED
Key Energy Services, Inc. Common Stock
KEG
| $18K | ﹤0.01% |
941
+862
| +1,091% | +$17.9K |
2016 Q4
2 quarters
|
|
|
NDRM
4331
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $18K | ﹤0.01% |
592
| – | – |
2017 Q1
1 quarter
|
|
4332
State Street SPDR S&P International Dividend ETF
DWX
$509M
| $17K | ﹤0.01% |
425
+294
| +224% | +$11.5K |
2017 Q1
1 quarter
|
|
4333
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.78B
| $17K | ﹤0.01% |
+534
| New | +$16.5K |
2017 Q2
0 quarters
|
|
4334
iShares US Consumer Staples ETF
IYK
$1.37B
| $17K | ﹤0.01% |
420
| – | – |
2016 Q1
5 quarters
|
|
4335
Kornit Digital
KRNT
$751M
| $17K | ﹤0.01% |
888
| – | – |
2017 Q1
1 quarter
|
|
4336
Marchex
MCHX
$57.2M
| $17K | ﹤0.01% |
5,675
-16,396
| -74% | -$46.3K |
2016 Q4
2 quarters
|
|
4337
Ohio Valley Banc Corp
OVBC
$210M
| $17K | ﹤0.01% |
+459
| New | +$14.7K |
2017 Q2
0 quarters
|
|
4338
Rocket Pharmaceuticals
RCKT
$281M
| $17K | ﹤0.01% |
2,202
+783
| +55% | +$5.84K |
2016 Q4
2 quarters
|
|
4339
Reading International Class A
RDI
$45M
| $17K | ﹤0.01% |
1,063
-10,097
| -90% | -$157K |
2016 Q4
2 quarters
|
|
|
RGLS
4340
DELISTED
Regulus Therapeutics
RGLS
| $17K | ﹤0.01% |
+140
| New | +$23.4K |
2017 Q2
0 quarters
|
|
|
CNXM
4341
DELISTED
CNX Midstream Partners LP
CNXM
| $17K | ﹤0.01% |
898
+723
| +413% | +$15.1K |
2014 Q3
11 quarters
|
|
|
FNJN
4342
DELISTED
Finjan Holdings, Inc.
FNJN
| $17K | ﹤0.01% |
+5,040
| New | +$13.1K |
2017 Q2
0 quarters
|
|
|
XRM
4343
DELISTED
Xerium Technologies Inc (new)
XRM
| $17K | ﹤0.01% |
+2,300
| New | +$16K |
2017 Q2
0 quarters
|
|
|
AHGP
4344
DELISTED
Alliance Holdings GP
AHGP
| $17K | ﹤0.01% |
+725
| New | +$19.9K |
2017 Q2
0 quarters
|
|
4345
Accuray
ARAY
$33.6M
| $16K | ﹤0.01% |
3,369
-1,353
| -29% | -$5.94K |
2014 Q3
11 quarters
|
|
4346
iShares MSCI BIC ETF
BKF
$67.5M
| $16K | ﹤0.01% |
+425
| New | +$15.8K |
2017 Q2
0 quarters
|
|
4347
Madison Square Garden
MSGS
$9.8B
| $16K | ﹤0.01% |
111
-33,594
| -100% | -$4.75M |
2013 Q2
16 quarters
|
|
4348
Materion
MTRN
$6.5B
| $16K | ﹤0.01% |
429
+60
| +16% | +$2.12K |
2016 Q4
2 quarters
|
|
4349
Sibanye-Stillwater
SBSW
$7.05B
| $16K | ﹤0.01% |
3,694
-480,481
| -99% | -$3.19M |
2013 Q2
16 quarters
|
|
4350
First Trust Cloud Computing ETF
SKYY
$3.43B
| $16K | ﹤0.01% |
407
| – | – |
2015 Q4
6 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.